Literature DB >> 12213734

Multiple head and neck tumors frequently originate from a single preneoplastic lesion.

Maarten P Tabor1, Ruud H Brakenhoff, Henrique J Ruijter-Schippers, Jacqueline E Van Der Wal, Gordon B Snow, C René Leemans, Boudewijn J M Braakhuis.   

Abstract

The development of second primary tumors has a negative impact on the prognosis of head and neck squamous cell carcinoma. Previously, we detected genetically altered and tumor-related mucosal lesions in the resection margins in 25% of unselected head and neck squamous cell carcinoma patients (Tabor MP, Brakenhoff RH, van Houten VMM, Kummer JA, Snel MHJ, Snijders PJF, Snow GB, Leemans CR, Braakhuis BJM: Persistence of genetically altered fields in head and neck cancer patients: biological and clinical implications. Clin Cancer Res 2001, 7: 1523-1532). The aim of this study was to determine whether first and second primary tumors are clonally related and originate from a single genetically altered field. From 10 patients we analyzed the first tumor of the oral cavity or oropharynx, the >3-cm remote second primary tumor, and the mucosa from the tumor-free margins from both resection specimens. We compared TP53 mutations and loss of heterozygosity profiles using 19 microsatellite markers at chromosomes 3p, 9p, 13q, and 17p. In all patients, genetically altered mucosal lesions were detected in at least one resection margin from both first and second primary tumor. Evidence for a common clonal origin of the first tumor, second primary tumor, and the intervening mucosa was found for at least 6 of 10 patients. Our results indicate that a proportion of multiple primary tumors have developed within a single preneoplastic field. Based on different etiology and clinical consequences, we propose that independent second primary tumors should be distinguished from second field tumors, that arise from the same genetically altered field the first tumor has developed from.

Entities:  

Mesh:

Year:  2002        PMID: 12213734      PMCID: PMC1867244          DOI: 10.1016/S0002-9440(10)64266-6

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  31 in total

1.  Use of allelic loss to predict malignant risk for low-grade oral epithelial dysplasia.

Authors:  M P Rosin; X Cheng; C Poh; W L Lam; Y Huang; J Lovas; K Berean; J B Epstein; R Priddy; N D Le; L Zhang
Journal:  Clin Cancer Res       Date:  2000-02       Impact factor: 12.531

2.  Field cancerization in oral stratified squamous epithelium; clinical implications of multicentric origin.

Authors:  D P SLAUGHTER; H W SOUTHWICK; W SMEJKAL
Journal:  Cancer       Date:  1953-09       Impact factor: 6.860

3.  Synchronous oral carcinomas: independent or common clonal origin?

Authors:  A G Scholes; J A Woolgar; M A Boyle; J S Brown; E D Vaughan; C A Hart; A S Jones; J K Field
Journal:  Cancer Res       Date:  1998-05-01       Impact factor: 12.701

4.  Multiple regions of deletion on chromosome arm 13q in head-and-neck squamous-cell carcinoma.

Authors:  V K Gupta; A P Schmidt; M E Pashia; J B Sunwoo; S B Scholnick
Journal:  Int J Cancer       Date:  1999-10-22       Impact factor: 7.396

5.  Location of candidate tumour suppressor gene loci at chromosomes 3p, 8p and 9p for oral squamous cell carcinomas.

Authors:  M Partridge; G Emilion; S Pateromichelakis; E Phillips; J Langdon
Journal:  Int J Cancer       Date:  1999-10-29       Impact factor: 7.396

Review 6.  Molecular assays for the diagnosis of minimal residual head-and-neck cancer: methods, reliability, pitfalls, and solutions.

Authors:  V M van Houten; M P Tabor; M W van den Brekel; F Denkers; R G Wishaupt; J A Kummer; G B Snow; R H Brakenhoff
Journal:  Clin Cancer Res       Date:  2000-10       Impact factor: 12.531

7.  Second esophageal tumors in patients with head and neck squamous cell carcinoma: an assessment of clonal relationships.

Authors:  J Califano; P L Leong; W M Koch; C F Eisenberger; D Sidransky; W H Westra
Journal:  Clin Cancer Res       Date:  1999-07       Impact factor: 12.531

8.  The origins of multiple squamous cell carcinomas in the aerodigestive tract.

Authors:  M G van Oijen; F G Leppers Vd Straat; M G Tilanus; P J Slootweg
Journal:  Cancer       Date:  2000-02-15       Impact factor: 6.860

9.  Mutagen sensitivity as a biomarker for second primary tumors after head and neck squamous cell carcinoma.

Authors:  J Cloos; C R Leemans; M L van der Sterre; D J Kuik; G B Snow; B J Braakhuis
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2000-07       Impact factor: 4.254

10.  p53 expression above the basal cell layer in oral mucosa is an early event of malignant transformation and has predictive value for developing oral squamous cell carcinoma.

Authors:  I B Cruz; P J Snijders; C J Meijer; B J Braakhuis; G B Snow; J M Walboomers; I van der Waal
Journal:  J Pathol       Date:  1998-04       Impact factor: 7.996

View more
  43 in total

1.  Loss of BCL-2 in the progression of oral cancer is not attributable to mutations.

Authors:  L L Loro; A C Johannessen; O K Vintermyr
Journal:  J Clin Pathol       Date:  2005-11       Impact factor: 3.411

Review 2.  Open questions and novel concepts in oral cancer surgery.

Authors:  Giancarlo Tirelli; Serena Zacchigna; Matteo Biasotto; Marco Piovesana
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-05-24       Impact factor: 2.503

3.  Comparison of "Lesion-by-Lesion" and Field Photodynamic Therapy in the Prevention of Actinic Keratoses: A Randomized, Split-Face, Single-Blind Pilot Study.

Authors:  Inge Seubring; Joannes M M Groenewoud; Marie-Jeanne P Gerritsen
Journal:  Dermatology       Date:  2017-01-18       Impact factor: 5.366

4.  The color of cancer: Margin guidance for oral cancer resection using elastic scattering spectroscopy.

Authors:  Gregory A Grillone; Zimmern Wang; Gintas P Krisciunas; Angela C Tsai; Vishnu R Kannabiran; Robert W Pistey; Qing Zhao; Eladio Rodriguez-Diaz; Ousama M A'Amar; Irving J Bigio
Journal:  Laryngoscope       Date:  2017-07-28       Impact factor: 3.325

Review 5.  Molecular biology of squamous cell carcinoma of the head and neck.

Authors:  B Perez-Ordoñez; M Beauchemin; R C K Jordan
Journal:  J Clin Pathol       Date:  2006-05       Impact factor: 3.411

6.  [Exploration of tumor suppressors p16INK4a and p14ARF in oral leukoplakias].

Authors:  Matthias Nitsche; Susanne Koy; Michael Mörz; Rainer Koch; Uwe Eckelt
Journal:  Mund Kiefer Gesichtschir       Date:  2007-11-08

Review 7.  Targeting cellular and molecular drivers of head and neck squamous cell carcinoma: current options and emerging perspectives.

Authors:  Simonetta Ausoni; Paolo Boscolo-Rizzo; Bhuvanesh Singh; Maria Cristina Da Mosto; Giacomo Spinato; Giancarlo Tirelli; Roberto Spinato; Giuseppe Azzarello
Journal:  Cancer Metastasis Rev       Date:  2016-09       Impact factor: 9.264

8.  Somatic acquisition of TGFBR1*6A by epithelial and stromal cells during head and neck and colon cancer development.

Authors:  Yansong Bian; Thomas J Knobloch; Maureen Sadim; Virginia Kaklamani; Adekunle Raji; Guang-Yu Yang; Christopher M Weghorst; Boris Pasche
Journal:  Hum Mol Genet       Date:  2007-09-21       Impact factor: 6.150

9.  Association of OPN overexpression with tumor stage, differentiation, metastasis and tumor progression in human laryngeal squamous cell carcinoma.

Authors:  Jianqiu Chen; Chunsheng Zhu; Zhen He; Min Geng; Guojun Li; Xiaofeng Tao; Fenghua Zhang
Journal:  Int J Clin Exp Med       Date:  2015-05-15

Review 10.  Tracing the "at-risk" oral mucosa field with autofluorescence: steps toward clinical impact.

Authors:  Catherine F Poh; Calum E MacAulay; Lewei Zhang; Miriam P Rosin
Journal:  Cancer Prev Res (Phila)       Date:  2009-04-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.